Literature DB >> 4992235

Successful treatment of osteomyelitis caused by Pseudomonas aeruginosa.

J W Harding, G T Braddock, E A Croydon.   

Abstract

A case of generalized osteomyelitis due to Ps. aeruginosa is described. The condition had failed to respond to therapy with almost all antibiotics available but responded to long-term therapy with carbenicillin in very large doses, and it is suggested that this is now the treatment of choice for severe infections due to this organism.

Entities:  

Mesh：

Substances：

Year:  1970        PMID： 4992235      PMCID： PMC476863          DOI： 10.1136/jcp.23.8.653

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN： 0021-9746            Impact factor:   3.411


  7 in total

1.  [PYOCYANEUS SEPSIS (WITH MENINGITIS AND OSTEOMYELITIS) IN INFANTS].

Authors:  H MATTERN
Journal:  Monatsschr Kinderheilkd       Date:  1965-04

2.  Synthesis of penicillin: 6-aminopenicillanic acid in penicillin fermentations.

Authors:  F R BATCHELOR; F P DOYLE; J H NAYLER; G N ROLINSON
Journal:  Nature       Date:  1959-01-24       Impact factor: 49.962

3.  Clinical and laboratory studies with carbenicillin. A new penicillin active against Pseudomonas pyocyanea.

Authors:  W Brumfitt; A Percival; D A Leigh
Journal:  Lancet       Date:  1967-06-17       Impact factor: 79.321

4.  Carbenicillin: a new semisynthetic penicillin active against Pseudomonas pyocyanea.

Authors:  E T Knudsen; G N Rolinson; R Sutherland
Journal:  Br Med J       Date:  1967-07-08

5.  Experiences with carbenicillin in the treatment of septicaemia and meningitis.

Authors:  A E Richardson; K W James; C R Spittle; O P Robinson
Journal:  Postgrad Med J       Date:  1968-11       Impact factor: 2.401

6.  Carbenicillin therapy of gram-negative bacilli infections.

Authors:  G P Bodey; V Rodriguez; J K Luce
Journal:  Am J Med Sci       Date:  1969-06       Impact factor: 2.378

7.  New semi-synthetic penicillin active against Pseudomonas pyocyanea.

Authors:  P Acred; D M Brown; E T Knudsen; G N Rolinson; R Sutherland
Journal:  Nature       Date:  1967-07-01       Impact factor: 49.962
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.